Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO, and AUA Evidence-Based GuidelineScott C. Morgan, Howard M. Sandler, C.A. Lawton et al.|Practical Radiation Oncology|2018Cited by 243
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based GuidelineScott C. Morgan, Howard M. Sandler, Karen E. Hoffman et al.|Journal of Clinical Oncology|2018Cited by 179
Stereotactic Radiotherapy for Oligoprogression in Metastatic Renal Cell Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Phase 2 Prospective Multicenter StudyPatrick Cheung, Georg A. Bjarnason, Samir Patel et al.|European Urology|2021Cited by 128
Hypofractionated Radiation Therapy for Localized Prostate Cancer: Executive Summary of an ASTRO, ASCO and AUA Evidence-Based GuidelineScott C. Morgan, Howard M. Sandler, Karen E. Hoffman et al.|The Journal of Urology|2019Cited by 87
Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based GuidelineScott C. Morgan, Howard M. Sandler, Karen E. Hoffman et al.|The Journal of Urology|2018Cited by 64